• $94.9M
    Market Cap
  • -49.01%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
35,000
0.00%
35,000
-68.18%
110,000
0.00%
110,000
-24.14%
Gross Profit
-35,000
0.00%
-35,000
-68.18%
-110,000
0.00%
-110,000
-24.14%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-11.0M
-22.59%
-14.2M
+257.00%
-4.0M
-77.79%
-18.0M
+5.64%
Depreciation and Amortization Expense
1,000
-98.41%
63,000
-47.06%
119,000
-29.59%
169,000
+39.67%
Total Operating Expenses
50.6M
-22.24%
65.1M
+300.05%
16.3M
-41.13%
27.6M
+3.92%
Operating Profit
-50.6M
-22.24%
-65.1M
+300.05%
-16.3M
-41.13%
-27.6M
+3.92%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
48,000
-92.99%
685,000
+25.92%
544,000
+71.07%
318,000
-27.89%
Income before Taxes
-50.6M
-22.24%
-65.1M
+300.05%
-16.3M
-41.13%
-27.6M
+3.92%
Income Taxes
-712,000
-53.89%
-1.5M
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-49.9M
-20.69%
-62.9M
+299.71%
-15.7M
-42.43%
-27.3M
+4.45%
Net Income from Continuing Operations Applicable to Common
-49.9M
-20.69%
-62.9M
+299.71%
-15.7M
-42.43%
-27.3M
+4.45%
Basic EPS and Net Income
-1.96
-44.16%
-3.51
+2.63%
-3.42
-43.19%
-6.02
+1,975.86%
Diluted EPS and Net Income
-1.96
-44.16%
-3.51
+2.63%
-3.42
-43.19%
-6.02
+1,975.86%
Basic Weighted Average Shares
25.4M
+41.84%
17.9M
+290.09%
4.6M
+1.31%
4.5M
-94.89%
Diluted Weighted Average Shares
25.4M
+41.84%
17.9M
+290.09%
4.6M
+1.31%
4.5M
-94.89%
Balance Sheet
Cash and Cash Equivalents
3.2M
-75.01%
12.9M
-25.69%
17.3M
+233.33%
5.2M
+44.28%
Short-Term Investments
N/A
N/A
N/A
N/A
16.0M
0.00%
16.0M
-62.09%
Cash and Cash Equivalents and Short-Term Investments
3.2M
-75.01%
12.9M
-61.44%
33.4M
+57.05%
21.2M
-53.75%
Total Current Assets
4.3M
-68.32%
13.7M
-25.23%
18.3M
-16.49%
21.9M
-54.60%
Accumulated Depreciation
N/A
N/A
N/A
N/A
358,000
+32.59%
270,000
+27.36%
Property and Plant and Equipment and Net
0
-100.00%
1,000
-94.74%
19,000
-72.86%
70,000
-45.31%
Total Long-Term Assets
2,000
0.00%
2,000
-99.91%
2.2M
+9,037.50%
24,000
0.00%
Total Assets
24.2M
-61.15%
62.2M
-41.33%
106.0M
+381.70%
22.0M
-54.61%
Income Taxes Payable
1.1M
-40.18%
1.8M
-46.72%
3.3M
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
6.2M
+7.50%
5.7M
+31.11%
4.4M
+29.58%
3.4M
-24.93%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
0
-100.00%
277,000
-95.84%
6.7M
+9,540.58%
69,000
0.00%
Total Liabilities
7.2M
-7.16%
7.8M
+1.13%
7.7M
+127.87%
3.4M
-26.07%
Retained Earnings
-401.3M
+14.19%
-351.4M
+21.80%
-288.5M
+5.77%
-272.8M
+11.13%
Total Stockholders Equity
45.0M
0.00%
45.0M
+553.48%
6.9M
-63.02%
18.6M
-57.58%
Total Shares Outstanding
27.6M
+27.16%
21.7M
+343.47%
4.9M
+7.58%
4.5M
-94.99%
Cash Flow
Cash from Operating Activities
-19.4M
-13.14%
-22.3M
+12.54%
-19.8M
-20.34%
-24.9M
+4.68%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
157,000
0.00%
Cash from Investing Activities
N/A
N/A
0
-100.00%
16.2M
-38.79%
26.5M
+173.67%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
9.8M
-45.25%
17.8M
+12.81%
15.8M
-71.62%
55.7M
0.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-115.51%
+54.48%
-74.77%
+204.22%
-24.58%
-68.30%
-77.54%
-3.94%
Return on Equity
-110.81%
-54.28%
-242.36%
+96.50%
-123.34%
+41.10%
-87.41%
-6.34%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.70
-70.53%
2.38
-42.97%
4.17
-35.55%
6.46
-39.52%
Cash Ratio
0.52
-76.75%
2.24
-43.32%
3.95
+157.23%
1.53
+92.20%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow